rs1131692331

chr4-42065323-TAGC-T

Variant summary

Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM4_Supporting PP5_Moderate

The NM_006345.4(SLC30A9):c.1049_1051del(p.Ala350del) variant causes a inframe deletion change involving the alteration of a conserved nucleotide. Variant has been reported in ClinVar as Pathogenic (★).

• Frequency: Genomes: not found (cov: 32)
• Consequence: SLC30A9 NM_006345.4 inframe_deletion
• Clinical Significance: Pathogenic criteria provided, single submitter P:2
• Conservation: PhyloP100: 8.79

Genes affected

SLC30A9 (HGNC:1329): (solute carrier family 30 member 9) Predicted to enable nuclear receptor coactivator activity. Involved in cellular zinc ion homeostasis and zinc ion transport. Located in several cellular components, including cytoplasmic vesicle; cytoskeleton; and endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2022]

ACMG classification

Verdict is Uncertain_significance. Variant got 3 ACMG points.

• PM4: Nonframeshift variant in NON repetitive region in NM_006345.4. Strenght limited to Supporting due to length of the change: 1aa.
• PP5: Variant 4-42065323-TAGC-T is Pathogenic according to our data. Variant chr4-42065323-TAGC-T is described in ClinVar as [Pathogenic]. Clinvar id is 431049.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	UniProt
SLC30A9	NM_006345.4	c.1049_1051del	p.Ala350del	inframe_deletion	12/18	ENST00000264451.12
SLC30A9	XM_047449525.1	c.1049_1051del	p.Ala350del	inframe_deletion	12/13

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Appris	UniProt
SLC30A9	ENST00000264451.12	c.1049_1051del	p.Ala350del	inframe_deletion	12/18	1	NM_006345.4	P1
SLC30A9	ENST00000509683.5	n.105_107del		non_coding_transcript_exon_variant	2/6	3
SLC30A9	ENST00000513699.5	c.*806_*808del		3_prime_UTR_variant, NMD_transcript_variant	13/19	2

Frequencies

GnomAD3 genomes Cov.: 32

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome Cov.: 32

ClinVar

Significance: Pathogenic

Submissions summary: Pathogenic:2

Revision: criteria provided, single submitter

Submissions by phenotype

Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome Pathogenic:2

Pathogenic, criteria provided, single submitter	research	UAEU Genomics Laboratory, United Arab Emirates University	Apr 08, 2023	The in-frame deletion NM_006345.4(SLC30A9):c.1049_1051delCAG (p.Ala350del) has been reported previously in 6 individuals from a Bedouin kindred affected with Birk-Landau-Perez syndrome (Perez et al., 2017). This variant is not present in gnomAD database (Karczewski et al., 2020) and Middle Eastern specific databases (Koshy et al., 2017). The removed amino acid is highly conserved and is located at the predicted cation-efflux domain of the mature SLC30A9 protein. In vitro functional studies in human neuroblastoma cells showed a significant decrease in cytosolic free Zn2+ levels in cells expressing the mutant compared to the wild type. (Perez et al., 2017).Further, in CRISPR-Cas9 knockout (SLC30A9 -/-) cell lines, functional complementation of the p.Ala350Del variant failed to restore the functional defect caused by genetic ablation of SLC30A9, indicating that the p.Ala350Del variant is a loss-of-function allele (Deng et al., 2021). Aggregating all the available evidence (PM2, PM1, PS3, PP1_strong), this variant has been classified as Pathogenic. -
Pathogenic, no assertion criteria provided	literature only	OMIM	Aug 08, 2017	- -

Computational scores

Source: dbNSFP v4.3

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.010		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs1131692331; hg19: chr4-42067340;